Mechanisms of diabetic neuropathy

Aguayo, 1977, Abnormal myelination in transplanted Trembler mouse Schwann cells, Nature, 265, 73, 10.1038/265073a0 Akude, 2010, 4-hydroxy-2-nonenal impairs mitochondrial physiology and induces aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy, Neurotox Res, 17, 28, 10.1007/s12640-009-9074-5 Arroyo, 2000, On the molecular architecture of myelinated fibers, Histochem Cell Biol, 113, 1, 10.1007/s004180050001 Balice-Gordon, 1998, Functional gap junctions in the Schwann cell myelin sheath, J Cell Biol, 142, 1095, 10.1083/jcb.142.4.1095 Ballin, 1968, Hypertrophic changes in diabetic neuropathy, Acta Neuropathol, 11, 93, 10.1007/BF00690213 Beggs, 1992, Innervation of the vasa nervorum: changes in human diabetics, J Neuropathol Exp Neurol, 51, 612, 10.1097/00005072-199211000-00006 Behse, 1975, Unmyelinated fibers and Schwann cells of sural nerve in neuropathy, Brain, 98, 493, 10.1093/brain/98.3.493 Behse, 1977, Nerve biopsy and conduction studies in diabetic neuropathy, J Neurol Neurosurg Psychiatry, 40, 1072, 10.1136/jnnp.40.11.1072 Beiswenger, 2008, Dissociation of thermal hypoalgesia and epidermal innervation in streptozotocin-diabetic mice, Neurosci Lett, 442, 267, 10.1016/j.neulet.2008.06.079 Bestetti, 1981, Changes in peripheral nerves of rats four months after induction of streptozotocin diabetes. A qualitative and quantitative study, Acta Neuropathol, 54, 129, 10.1007/BF00689405 Bhat, 2003, Molecular organization of axo-glial junctions, Curr Opin Neurobiol, 13, 552, 10.1016/j.conb.2003.09.004 Bianchi, 1990, Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study, Diabetologia, 33, 131, 10.1007/BF00404038 Bianchi, 2004, Erythropoetin both protects from and reverses experimental diabetic neuropathy, Proc Natl Acad Sci U S A, 101, 823, 10.1073/pnas.0307823100 Bischoff, 1980, Morphology of diabetic neuropathy, Horm Metab Res Suppl., 9, 18 Bolin, 1995, Interleukin-6 production by Schwann cells and induction in sciatic nerve injury, J Neurochem, 64, 850, 10.1046/j.1471-4159.1995.64020850.x Boucek, 2005, Severe depletion of intraepidermal nerve fibers in skin biopsies of pancreas transplant recipients, Transplant Proc, 37, 3574, 10.1016/j.transproceed.2005.09.047 Bradley, 1990, Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy, Diabetologia, 33, 611, 10.1007/BF00400205 Bradley, 1994, A comparison of perineurial and vascular basal lamina changes in diabetic neuropathy, Acta Neuropathol, 88, 426, 10.1007/BF00389494 Bradley, 2000, The extracellular matrix of peripheral nerve in diabetic polyneuropathy, Acta Neuropathol, 99, 539, 10.1007/s004010051158 Bravenboer, 1992, Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat, Diabetologia, 35, 813, 10.1007/BF00399926 Britland, 1990, Association of painful and painless diabetic neuropathy with different patterns of nerve fiber degeneration and regeneration, Diabetes, 39, 898, 10.2337/diab.39.8.898 Brownlee, 1992, Glycation products and the pathogenesis of diabetic complications, Diabetes Care, 15, 1835, 10.2337/diacare.15.12.1835 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Brownlee, 2005, The pathobiology of diabetic complications. A unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615 Brussee, 2004, Direct insulin signaling of neurons reverses diabetic neuropathy, Diabetes, 53, 1824, 10.2337/diabetes.53.7.1824 Bunge, 1993, Expanding roles for the Schwann cell: ensheathment, myelination, trophism, and regeneration, Curr Opin Neurobiol, 3, 805, 10.1016/0959-4388(93)90157-T Bunge, 1993, Regulation of extracellular matrix biosynthesis and assembly, 299 Calcutt, 1992, Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats, Brain Res, 575, 320, 10.1016/0006-8993(92)90097-S Calcutt, 1999, Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders peripheral nerve in diabetic rats, J Neuropathol Exp Neurol, 58, 628, 10.1097/00005072-199906000-00007 Calcutt, 2003, Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy, J Clin Invest, 111, 507, 10.1172/JCI200315792 Calcutt, 2004, Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor, Diabetologia, 47, 718, 10.1007/s00125-004-1354-2 Calcutt, 2008, Growth factors as therapeutics for diabetic neuropathy, Curr Drug Targets, 9, 47, 10.2174/138945008783431727 Cameron, 1997, Metabolic and vascular factors in the pathogenesis of diabetic neuropathy, Diabetes, 46, S31, 10.2337/diab.46.2.S31 Cameron, 1999, Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes, Diabetes Res Clin Pract, 45, 137, 10.1016/S0168-8227(99)00043-1 Cameron, 2001, Effects of extracellular metal chelator on neurovascular function in diabetic rats, Diabetologia, 44, 621, 10.1007/s001250051669 Cameron, 1991, Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+K+-ATPase activity and vascular supply in STZ-diabetic rats, Diabetes, 40, 1652, 10.2337/diab.40.12.1652 Cameron, 1992, Muscle and nerve dysfunction in rats with experimental galactosaemia, Exp Physiol, 77, 89, 10.1113/expphysiol.1992.sp003585 Cameron, 1993, Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats, Diabetologia, 36, 299, 10.1007/BF00400231 Cameron, 1994, Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats, Diabetologia, 37, 449, 10.1007/s001250050131 Cameron, 1996, Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats, Diabetologia, 39, 172, 10.1007/BF00403960 Cameron, 1998, Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids, Diabetologia, 41, 390, 10.1007/s001250050921 Carlsen, 1980, Three dimensional analysis of Schwann cells associated with unmyelinated nerve fibers in human sural nerve, J Anat, 130, 545 Catterall, 2005, International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels, Pharmacol Rev, 57, 397, 10.1124/pr.57.4.4 Chakrabarti, 1987, Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve, Diabetologia, 30, 244, 10.1007/BF00270423 Cherian, 1996, Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition, J Diabetes Complications, 10, 192, 10.1016/1056-8727(95)00084-4 Chopra, 1969, The pathogenesis of sural nerve changes in diabetes mellitus, Brain, 92, 391, 10.1093/brain/92.2.391 Collins, 1964, The ultrastructure of myelin and axonal alterations in sciatic nerves of thiamine deficient and chronically starved rats, Acta Neuropathol, 3, 511, 10.1007/BF00688459 Conti, 1993, Myelin protein transcripts increase in experimental diabetes, Neurosci Lett, 161, 203, 10.1016/0304-3940(93)90294-U Conti, 1996, In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy, Neurosci Lett, 207, 65, 10.1016/0304-3940(96)12490-3 Cotter, 1995, Effects of acetyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes, Metabolism, 44, 1209, 10.1016/0026-0495(95)90018-7 Cullum, 1991, Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus, Diabetologia, 34, 387, 10.1007/BF00403175 Cunha, 2008, Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors, Metabolism, 57, 873, 10.1016/j.metabol.2008.01.021 Curtis, 1993, Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury, Nature, 16, 253, 10.1038/365253a0 Curtis, 1994, Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve, Neuron, 12, 191, 10.1016/0896-6273(94)90163-5 De Grandis, 2002, Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomized, double-blind, placebo-controlled study, Drugs R D, 3, 223, 10.2165/00126839-200203040-00001 de Waegh, 1991, Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts, J Neurosci Res, 30, 201, 10.1002/jnr.490300121 de Waegh, 1992, Local modulation of neurofilaments phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells, Cell, 68, 451, 10.1016/0092-8674(92)90183-D Devaux, 2004, KCNQ2 is a nodal K+ channel, J Neurosci, 24, 1236, 10.1523/JNEUROSCI.4512-03.2004 Dowsing, 1999, Leukemia inhibitory factor is an autocrine survival factor for Schwann cells, J Neurochem, 73, 96, 10.1046/j.1471-4159.1999.0730096.x Drel, 2006, The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity, Diabetes, 55, 3335, 10.2337/db06-0885 Dyck, 1980, Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry, Ann Neurol, 8, 590, 10.1002/ana.410080608 Dyck, 1985, Capillary number and percentage closed in human diabetic sural nerve, Proc Natl Acad Sci U S A, 82, 2513, 10.1073/pnas.82.8.2513 Eames, 1970, Schwann cell relationships in normal human cutaneous nerves, J Anat, 106, 417 Eaton, 1996, Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis, Diabetologia, 39, 439, 10.1007/BF00400675 Eckersley, 2002, Role of the Schwann cell in diabetic neuropathy, Int Rev Neurobiol, 50, 293, 10.1016/S0074-7742(02)50081-7 Engelstad, 1997, No evidence for axonal atrophy in human diabetic polyneuropathy, J Neuropathol Exp Neurol, 56, 255, 10.1097/00005072-199703000-00004 Eshed, 2007, Secreted gliomedin is a perinodal matrix component of peripheral nerves, J Cell Biol, 177, 551, 10.1083/jcb.200612139 Estrella, 2008, Endoneurial microvascular pathology in feline diabetic neuropathy, Microvasc Res, 75, 403, 10.1016/j.mvr.2007.12.002 Fagerberg, 1959, Diabetic neuropathy. A clinical and histological study on the significance of vascular affections, Acta Med Scand Suppl, 86, 345 Fannon, 1995, Novel E-cadherin mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions, J Cell Biol, 129, 189, 10.1083/jcb.129.1.189 Fawcett, 1990, Peripheral nerve regeneration, Annu Rev Neurosci, 13, 43, 10.1146/annurev.neuro.13.1.43 Feinberg, 2010, A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier, Neuron, 65, 490, 10.1016/j.neuron.2010.02.004 Feltri, 2008, The function of RhoGTPases in axon ensheathment and myelination, Glia, 56, 1508, 10.1002/glia.20752 Fernyhough, 1995, Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats, J Neurochem, 64, 1231, 10.1046/j.1471-4159.1995.64031231.x Fernyhough, 1998, Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats, Diabetologia, 41, 300, 10.1007/s001250050907 Fernyhough, 2003, Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy, J Peripher Nerv Syst, 8, 227, 10.1111/j.1085-9489.2003.03028.x Forcier, 1991, Cellular pathology of the nerve microenvironment in galactose intoxication, J Neuropathol Exp Neurol, 50, 235, 10.1097/00005072-199105000-00006 Funakoshi, 1993, Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve, J Cell Biol, 123, 455, 10.1083/jcb.123.2.455 Gabbay, 1968, The sorbitol pathway – enzyme localization and content in normal and diabetic nerve and cord, Diabetes, 17, 239, 10.2337/diab.17.5.239 Gabbay, 1972, Nerve conduction defect in galactose-fed rats, Diabetes, 21, 295, 10.2337/diab.21.5.295 Gabbay, 1966, Sorbitol pathway: presence on nerve and cord with substrate accumulation in diabetes, Science, 151, 209, 10.1126/science.151.3707.209 Gao, 1999, IGF-1 deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-1 treatment, J Neurobiol, 39, 142, 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H Gartner, 1989, Experimental autonomic neuropathy in the choroids of streptozotocin-diabetic rats. Electron microscopic observations, Retina, 9, 49, 10.1097/00006982-198909010-00007 Gatzinsky, 1997, Removal of retrogradely transported material from rat lumbosacral alpha-motor neurons by paranodal axon-Schwann cell networks, Glia, 20, 115, 10.1002/(SICI)1098-1136(199706)20:2<115::AID-GLIA3>3.0.CO;2-8 Gatzinsky, 2003, Early onset of degenerative changes at nodes of Ranvier in alpha-motor neurons of Cntf null (−/−) mutant mice, Glia, 42, 340, 10.1002/glia.10221 Ghani, 1999, Perineurial abnormalities in the spontaneously diabetic dog, Acta Neuropathol, 97, 98, 10.1007/s004010050961 Giannini, 1994, Ultrastructural morphometric abnormalities of sural nerve microvessels in diabetes mellitus, Ann Neurol, 36, 408, 10.1002/ana.410360312 Gibran, 2002, Diminished neuropeptide levels contribute to impaired cutaneous healing response associated with diabetes mellitus, J Surg Res, 108, 122, 10.1006/jsre.2002.6525 Gold, 1991, Regulation of axonal caliber, neurofilament content and nuclear localization in mature sensory neurons by nerve growth factor, J Neurosci, 11, 943, 10.1523/JNEUROSCI.11-04-00943.1991 Greene, 1988, Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?, Diabetes, 37, 688, 10.2337/diab.37.6.688 Griffey, 1988, Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy, JAMA, 260, 2872, 10.1001/jama.1988.03410190120034 Grinspan, 1996, Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins, J Neurosci, 16, 6107, 10.1523/JNEUROSCI.16-19-06107.1996 Hellweg, 1990, Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy, J Neurosci Res, 26, 258, 10.1002/jnr.490260217 Hirai, 2000, Evaluation of diabetic neuropathy through quantitation of cutaneous nerves, J Neurol Sci, 172, 55, 10.1016/S0022-510X(99)00290-7 Hohman, 1997, Increased oxidative stress in experimental diabetic neuropathy, Diabetologia, 40, A549 Hounsom, 2001, Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy, Diabetologia, 44, 424, 10.1007/s001250051638 Huang, 2003, Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type I diabetic rats in the presence of sustained hyperglycemia, Diabetes, 52, 2129, 10.2337/diabetes.52.8.2129 Ichimura, 1991, Three-dimensional fine structure of cytoskeletal-membrane interactions at nodes of Ranvier, J Neurocytol, 20, 667, 10.1007/BF01187068 Ihara, 1996, Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats, Neuropeptides, 30, 309, 10.1016/S0143-4179(96)90018-9 Jacobs, 1972, Aggregations of filaments in Schwann cells of spinal roots of the normal rat, J Neurocytol, 1, 161, 10.1007/BF01099182 Jakobsen, 1976, Axonal dwindling in early experimental diabetes. I A study of cross sectioned nerves, Diabetologia, 12, 539, 10.1007/BF01220629 Jakobsen, 1976, Axonal dwindling in early experimental diabetes. II A study of isolated nerve fibres, Diabetologia, 12, 547, 10.1007/BF01220630 Jakobsen, 1978, Peripheral nerves in early experimental diabetes. Expansion of the endoneurial space as a cause of increased water content, Diabetologia, 14, 113, 10.1007/BF01263449 Jessen, 2005, The origin and development of glial cells in peripheral nerves, Nat Rev Neurosci, 6, 671, 10.1038/nrn1746 Jiang, 2006, Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats, J Peripher Nerv Syst, 11, 274, 10.1111/j.1529-8027.2006.00099.x Jirmanova, 1993, Giant axonopathy in streptozotocin diabetes of rats, Acta Neuropathol, 86, 42, 10.1007/BF00454897 Johnson, 1984, Dermal nerves in human diabetic subjects, Diabetes, 33, 244, 10.2337/diab.33.3.244 Johnson, 1981, Human diabetic perineurial cell basement membrane thickening, Lab Invest, 44, 265 Johnson, 1986, Pathogenesis of diabetic neuropathy, Ann Neurol, 19, 450, 10.1002/ana.410190505 Johnson, 1988, Expression and possible function of nerve growth factor receptors on Schwann cells, Trends Neurosci, 7, 299, 10.1016/0166-2236(88)90090-2 Kalichman, 1998, Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes, Brain Res, 810, 130, 10.1016/S0006-8993(98)00898-1 Kalichman, 1998, Reactive, degenerative and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy, Acta Neuropathol, 95, 47, 10.1007/s004010050764 Kamijo, 1994, Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy, Diabetes Res Clin Pract, 25, 117, 10.1016/0168-8227(94)90037-X Kamiya, 2004, C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes, Ann Neurol, 56, 827, 10.1002/ana.20295 Kamiya, 2006, C-peptide reverses nociceptive neuropathy in type 1 diabetes, Diabetes, 55, 3581, 10.2337/db06-0396 Kato, 1994, Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine]-2-carbo amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats, J Diabetes Complications, 8, 27, 10.1016/1056-8727(94)90007-8 Kato, 2000, Effects of 15-month aldose reductase inhibition with fidarestat on experimental diabetic neuropathy in rats, Diabetes Res Clin Pract, 50, 77, 10.1016/S0168-8227(00)00164-9 Kawashima, 2007, Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats, Neurochem Res, 32, 1002, 10.1007/s11064-006-9260-2 Kennedy, 2005, Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?, Diabetes, 54, 830, 10.2337/diabetes.54.3.830 Kennedy, 1996, Quantitation of epidermal nerves in diabetic neuropathy, Neurology, 47, 1042, 10.1212/WNL.47.4.1042 Kern, 1982, Immunohistochemical distribution of aldose reductase, Histochem J, 14, 507, 10.1007/BF01011860 King, 1988, Perineurial calcification, Neuropathol Appl Neurobiol, 14, 105, 10.1111/j.1365-2990.1988.tb00874.x King, 1989, Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy, Neuropathol Appl Neurobiol, 15, 339, 10.1111/j.1365-2990.1989.tb01234.x Kishi, 1999, Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy, Diabetes, 48, 2045, 10.2337/diabetes.48.10.2045 Kishi, 2002, Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy, Diabetes, 51, 819, 10.2337/diabetes.51.3.819 Konishi, 1990, Voltage-gated potassium currents in myelinating Schwann cells in the mouse, J Physiol, 431, 123, 10.1113/jphysiol.1990.sp018323 Korthals, 1988, Intima of epineurial arterioles is increased in diabetic neuropathy, Neurology, 38, 1582, 10.1212/WNL.38.10.1582 Koskinen, 2005, A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy, J Neurol, 252, 789, 10.1007/s00415-005-0743-x Labasque, 2010, GPI-anchored proteins at the node of Ranvier, FEBS Lett, 584, 1787, 10.1016/j.febslet.2009.08.025 Lambourne, 1987, Opposite effects of diabetes and galactosemia on adenosine triphosphatase activity in rat nervous tissue, Diabetologia, 30, 360, 10.1007/BF00299031 Lamontagne, 1970, Electrophysiological studies in diabetes mellitus, J Neurol Neurosurg Psychiatry, 33, 442, 10.1136/jnnp.33.4.442 Lauria, 1998, Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy, J Neurol Neurosurg Psychiatry, 65, 762, 10.1136/jnnp.65.5.762 Lauria, 2005, Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation, J Peripher Nerv Syst, 10, 202, 10.1111/j.1085-9489.2005.0010210.x Leonelli, 2007, Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodel analysis, Neuroscience, 144, 1293, 10.1016/j.neuroscience.2006.11.014 Levy, 1989, Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study, Diabetologia, 32, 427, 10.1007/BF00271262 Levy, 1992, Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function, Diabetologia, 35, 889, 10.1007/BF00399938 Lindberger, 1989, Nerve fibre studies in skin biopsies in peripheral neuropathies, J Neurol Sci, 93, 289, 10.1016/0022-510X(89)90198-6 Lindholm, 1987, Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve, Nature, 330, 658, 10.1038/330658a0 Llewelyn, 1987, Sodium, potassium adenosine triphosphatase activity in peripheral nerve tissue of galactosemic rats. Effects of aldose reductase inhibition, Diabetologia, 30, 971, 10.1007/BF00295885 Llewelyn, 1991, Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy, Brain, 114, 867, 10.1093/brain/114.2.867 Love, 1996, Effects of sulphydryl donor N-acetyl-L-cytsteine on nerve conduction: perfusion, maturation and regeneration freeze-damage in diabetic rats, Eur J Clin Invest, 26, 698, 10.1111/j.1365-2362.1996.tb02156.x Love, 1996, Nerve function and regeneration in diabetic and galactosemic rats: antioxidant and metal chelator effects, Eur J Pharmacol, 31, 433 Low, 1991, Oxygen free radicals in sciatic nerve in experimental diabetes, Diabetes, 40, 873, 10.2337/diab.40.7.873 Low, 1997, The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy, Diabetes, 46, S38, 10.2337/diab.46.2.S38 Lowitt, 1995, Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes, Metabolism, 44, 677, 10.1016/0026-0495(95)90128-0 Ludvigson, 1980, Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation – localization in peripheral nerve, artery and testis, Diabetes, 29, 438, 10.2337/diab.29.6.438 Lui, 2002, Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites, Ann N Y Acad Sci, 959, 133, 10.1111/j.1749-6632.2002.tb02090.x Mackenzie, 1984, Nodes of Ranvier and Schmidt-Lanterman incisures: an in vivo lanthanum tracer study, J Neurocytol, 13, 1043, 10.1007/BF01148601 Malik, 1989, Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy, Diabetologia, 32, 92, 10.1007/BF00505180 Malik, 1992, Endoneurial capillary abnormalities in mild human diabetic neuropathy, J Neurol Neurosurg Psychiatry, 55, 557, 10.1136/jnnp.55.7.557 Malik, 1993, Endoneurial localization of microvascular damage in human diabetic neuropathy, Diabetologia, 36, 454, 10.1007/BF00402283 Malik, 1994, Transperineurial abnormalities in the sural nerve of patients with diabetic neuropathy, Microvasc Res, 48, 236, 10.1006/mvre.1994.1051 Malik, 2005, Sural nerve pathology in diabetic patients with minimal but progressive neuropathy, Diabetologia, 48, 578, 10.1007/s00125-004-1663-5 Mann, 1981 Matsuoka, 1991, Differential regulation of nerve growth factor and brain-derived neurotrophic factor expression in the peripheral nervous system, Ann N Y Acad Sci, 633, 550, 10.1111/j.1749-6632.1991.tb15657.x Maxwell, 1969, The trigeminal nerve root with special references to the central-peripheral transition zone: an electron microscopic study in the macaque, Anat Rec, 164, 113, 10.1002/ar.1091640108 McCallum, 1986, The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes, J Neurol Sci, 74, 55, 10.1016/0022-510X(86)90191-7 Medori, 1985, Experimental diabetic neuropathy: impairment of slow axonal transport with changes in axon cross-sectional area, Proc Natl Acad Sci U S A, 82, 7716, 10.1073/pnas.82.22.7716 Meier, 1999, Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving IGF, NT-3, and PDGF-BB, J Neurosci, 19, 3847, 10.1523/JNEUROSCI.19-10-03847.1999 Mendell, 1978, Immunocytochemical localization studies of myelin basic protein, J Cell Biol, 76, 502, 10.1083/jcb.76.2.502 Meyer, 1992, Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF m RNA, J Cell Biol, 119, 45, 10.1083/jcb.119.1.45 Mi, 1996, Inwardly rectifying K+ channels that may participate in K+ buffering are localized in microvilli of Schwann cells, J Neurosci, 16, 2421, 10.1523/JNEUROSCI.16-08-02421.1996 Mirsky, 1999, Schwann cell-derived desert hedgehog signals nerve sheath formation, Ann N Y Acad Sci, 14, 196, 10.1111/j.1749-6632.1999.tb08582.x Mizisin, 1991, Dose-dependent alterations in nerve polyols and (Na+, K+)-ATPase activity in galactose intoxication, Metabolism, 40, 1207, 10.1016/0026-0495(91)90217-K Mizisin, 1993, Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication, J Neuropathol Exp Neurol, 52, 78, 10.1097/00005072-199301000-00010 Mizisin, 2003, Diabetic peripheral neuropathy, 83 Mizisin, 1986, Endoneurial sodium accumulation in galacotsemic rat nerves, Muscle Nerve, 9, 440, 10.1002/mus.880090509 Mizisin, 1986, Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor, J Neurol Sci, 74, 35, 10.1016/0022-510X(86)90189-9 Mizisin, 1988, Dose-dependence of endoneurial fluid sodium and chloride accumulation in galactose intoxication, J Neurol Sci, 86, 113, 10.1016/0022-510X(88)90091-3 Mizisin, 1997, BDNF attenuates functional and structural disorders in nerves of galactose-fed rats, J Neuropathol Exp Neurol, 56, 1290, 10.1097/00005072-199712000-00004 Mizisin, 1997, Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats, Diabetes, 46, 647, 10.2337/diab.46.4.647 Mizisin, 1998, NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats, J Neuropathol Exp Neurol, 57, 803, 10.1097/00005072-199809000-00001 Mizisin, 1998, Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy, Acta Neuropathol, 95, 171, 10.1007/s004010050783 Mizisin, 1999, Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats, J Peripher Nerv Syst, 4, 211 Mizisin, 1999, Decreased accumulation of endogenous brain-derived neurotrophic factor against constricting sciatic nerve ligatures in streptozotocin-diabetic and galactose-fed rats, Neurosci Lett, 263, 1, 10.1016/S0304-3940(99)00131-7 Mizisin, 2001, TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats, J Neuropathol Exp Neurol, 60, 953, 10.1093/jnen/60.10.953 Mizisin, 2002, Neurological complications associated with spontaneously occurring feline diabetes mellitus, J Neuropathol Exp Neurol, 61, 872, 10.1093/jnen/61.10.872 Mizisin, 2004, Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats, Diabetes, 53, 1807, 10.2337/diabetes.53.7.1807 Mizisin, 2007, Comparable myelinated nerve pathology in feline and human diabetes mellitus, Acta Neuropathol, 113, 431, 10.1007/s00401-006-0163-8 Moore, 1982, Ultrastructrual axonal pathology in experimentally diabetic and aging control rats, Brain Res Bull, 8, 317, 10.1016/0361-9230(82)90065-X Murakawa, 2002, Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy, Diabetes Metab Res Rev, 18, 473, 10.1002/dmrr.326 Murinson, 2004, C-fiber structure varies with location in peripheral nerve, J Neuropathol Exp Neurol, 63, 246, 10.1093/jnen/63.3.246 Myers, 1984, Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow, Ann Neurol, 16, 587, 10.1002/ana.410160510 Myers, 1979, Increased endoneurial fluid pressure in galactose neuropathy, Muscle Nerve, 2, 299, 10.1002/mus.880020410 Nagafuchi, 1993, Transmembrane control of cadherin-mediated cell-cell adhesion, Semin Cell Biol, 4, 175, 10.1006/scel.1993.1021 Nagamatsu, 1995, Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy, Diabetes Care, 18, 1160, 10.2337/diacare.18.8.1160 Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121 Oates, 2002, Polyol pathway and diabetic peripheral neuropathy, Int Rev Neurobiol, 50, 326 Obrosova, 2002, How does glucose generate oxidative stress in peripheral nerve?, Int Rev Neurobiol, 50, 3, 10.1016/S0074-7742(02)50071-4 Obrosova, 2001, Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetes, Exp Neurol, 172, 211, 10.1006/exnr.2001.7789 Obrosova, 2008, PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy, Free Radic Biol Med, 44, 972, 10.1016/j.freeradbiomed.2007.09.013 Ohi, 1998, Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor, Exp Neurol, 151, 215, 10.1006/exnr.1998.6821 Ohnishi, 1983, Segmental demyelination and remyelination in lumbar spinal roots of patients dying with diabetes mellitus, Ann Neurol, 13, 541, 10.1002/ana.410130512 Pare, 2007, Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes, J Comp Neurol, 501, 543, 10.1002/cne.21262 Parmantier, 1999, Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheaths, Neuron, 23, 713, 10.1016/S0896-6273(01)80030-1 Pittenger, 2004, Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients, Diabetes Care, 27, 1974, 10.2337/diacare.27.8.1974 Powell, 1983, Schwann cell changes in chronic galactose neuropathy, Muscle Nerve, 6, 218, 10.1002/mus.880060309 Powell, 1977, Alloxan diabetic neuropathy: electron microscopic studies, Neurology, 27, 60, 10.1212/WNL.27.1.60 Powell, 1985, Microangiopathy in human diabetic neuropathy, Acta Neuropathol, 68, 295, 10.1007/BF00690832 Powell, 1991, Fine-structural localization of aldose reductase and ouabain-sensitive, K+-dependent p-nitro-phenylphosphatase in rat peripheral nerve, Acta Neuropathol, 81, 529, 10.1007/BF00310134 Privat, 1979, Absence of the major dense line in myelin of the mutant mouse ‘shiverer, Neurosci Lett, 12, 107, 10.1016/0304-3940(79)91489-7 Properzi, 1993, Early increase precedes a depletion of VIP and PGP9.5 in the skin of insulin-dependent diabetics – correlation between quantitative immunohistochemistry and clinical assessment of peripheral neuropathy, J Pathol, 169, 269, 10.1002/path.1711690215 Pu, 1995, Differential spatio-temporal expression of the insulin-like growth factor genes in regenerating sciatic nerve, Mol Brain Res, 34, 18, 10.1016/0169-328X(95)00116-A Rende, 1992, Localization and characterization of ciliary neuronotrophic factor in peripheral nerve, Glia, 5, 25, 10.1002/glia.440050105 Robertson, 1980, Diabetic neuropathy in the mutant [C57BL/ks(db/db)]: a morphometric study, Diabetes, 29, 60, 10.2337/diab.29.1.60 Rodriguez-Pena, 1995, Expression of neurotrophins and their receptors in sciatic nerve of experimentally diabetic rats, Neurosci Lett, 200, 37, 10.1016/0304-3940(95)12067-E Roglio, 2007, Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy, Cell Mol Life Sci, 64, 1158, 10.1007/s00018-007-7002-5 Rosen, 2001, The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society, Diabetes Metab Res Rev, 17, 189, 10.1002/dmrr.196 Russell, 1999, Neurons undergo apoptosis in animal and cell culture models of diabetes, Neurobiol Dis, 6, 347, 10.1006/nbdi.1999.0254 Ryle, 1997, Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus, Muscle Nerve, 20, 577, 10.1002/(SICI)1097-4598(199705)20:5<577::AID-MUS6>3.0.CO;2-6 Said, 1983, Progressive centripedal degeneration of axons in small fiber type diabetic polyneuropathy. A clinical and pathological study, Brain, 106, 791, 10.1093/brain/106.4.791 Sandri, 1982, Membrane morphology of the vertebrate nervous system, Prog Brain Res, 46, 201 Sasaki, 1997, Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats, Acta Neuropathol, 93, 118, 10.1007/s004010050592 Sawada, 1999, Ganglioside GD1 alpha analogues as high-affinity ligands fro myelin-associated glycoprotein (MAG), Carbohydr Res, 316, 1, 10.1016/S0008-6215(99)00081-6 Schmeichel, 2003, Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy, Diabetes, 52, 165, 10.2337/diabetes.52.1.165 Schmidt, 1999, Insulin-like growth factor 1 reverses experimental diabetic autonomic neuropathy, Am J Pathol, 155, 1651, 10.1016/S0002-9440(10)65480-6 Schmidt, 2005, Analysis of the Zucker diabetic fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-1 in diabetic autonomic neuropathy, Am J Pathol, 163, 21, 10.1016/S0002-9440(10)63626-7 Shapiro, 1995, Structural basis of cell-cell adhesion by cadherins, Nature, 374, 327, 10.1038/374327a0 Sharghi-Namini, 2006, The structural and functional integrity of peripheral nerves depends on the glial-derived signal desert hedgehog, J Neurosci, 26, 6364, 10.1523/JNEUROSCI.0157-06.2006 Sharma, 1983, Peripheral nerve abnormalities in the diabetic mutant mouse, Diabetes, 32, 1152, 10.2337/diab.32.12.1152 Shun, 2004, Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments, Brain, 127, 1593, 10.1093/brain/awh180 Sima, 1980, Peripheral neuropathy in the spontaneously diabetic BB-Wistar-rat. An ultrastructural study, Acta Neuropathol, 51, 223, 10.1007/BF00687389 Sima, 2008, Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?, Curr Drug Targets, 9, 37, 10.2174/138945008783431745 Sima, 1978, Peripheral neuropathy in the mutant diabetic mouse [C57BL/Ks (db/db)], Acta Neuropathol, 41, 85, 10.1007/BF00689757 Sima, 1979, Peripheral neuropathy in the diabetic mutant mouse. An ultrastructural study, Lab Invest, 40, 627 Sima, 1983, Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy, Ann Neurol, 13, 264, 10.1002/ana.410130307 Sima, 1986, Axo-glial dysjunction: a novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat, J Clin Invest, 77, 474, 10.1172/JCI112326 Sima, 1988, Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy, J Clin Invest, 81, 349, 10.1172/JCI113327 Sima, 1991, Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor, Diabetes, 40, 1090, 10.2337/diab.40.9.1090 Sima, 1993, Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity, Diabet Med, 10, 115, 10.1111/j.1464-5491.1993.tb00027.x Sima, 1996, Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the biobreeding Worcester rat, J Clin Invest, 97, 1900, 10.1172/JCI118621 Singhal, 1997, Near nerve local insulin prevents conduction slowing in experimental diabetes, Brain Res, 763, 209, 10.1016/S0006-8993(97)00412-5 Smith, 2005, Epidermal nerve fiber innervation in impaired glucose tolerance and diabetes-associated neuropathy, Neurology, 57, 1701, 10.1212/WNL.57.9.1701 Spencer, 1978, Pathobiology of neurotoxic axonal degeneration, 265 Spencer, 1974, Ultrastructural studies of the dying-back process II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons, J Neurocytol, 3, 763, 10.1007/BF01097197 Sredy, 1991, Adenosine triphosphatase activity in sciatic nerve tissue of streptozotocin-induced diabetic rats with and without high dietary sucrose: effects of aldose reductase inhibition, Proc Soc Exp Med, 197, 135, 10.3181/00379727-197-43235 Srinivasan, 2000, Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction, Diabetes, 49, 1932, 10.2337/diabetes.49.11.1932 Stevens, 1995, Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy, Diabet Med, 12, 292, 10.1111/j.1464-5491.1995.tb00478.x Stevens, 1994, The linked roles of nitric oxide, aldose reductase and (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin-diabetic rat, J Clin Invest, 94, 853, 10.1172/JCI117406 Stevens, 2000, Effect of DL-a-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy, Diabetes, 49, 1006, 10.2337/diabetes.49.6.1006 Stoll, 1989, Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation, J Neurocytol, 18, 671, 10.1007/BF01187086 Sugimoto, 1997, Effects of aminoguanidine on structural alterations in microvessels in peripheral nerve of streptozotocin diabetic rats, Microvasc Res, 53, 105, 10.1006/mvre.1996.2002 Sugimoto, 1997, Localization in human diabetic peripheral nerve of N(epsilon)-carbxymethyl-lysine-protein adducts, an advanced glycation endproduct, Diabetologia, 40, 1380, 10.1007/s001250050839 Sugimoto, 2000, Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms, Diabetes Metab Res Rev, 16, 354, 10.1002/1520-7560(200009/10)16:5<354::AID-DMRR149>3.0.CO;2-H Sugimoto, 2008, Role of advanced glycation end products in diabetic neuropathy, Curr Pharm Des, 14, 953, 10.2174/138161208784139774 Sugimura, 1981, Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy, J Neurol Sci, 53, 501, 10.1016/0022-510X(82)90246-5 Suter, 1995, Biology and genetics of hereditary motor and sensory neuropathies, Annu Rev Neurosci, 18, 45, 10.1146/annurev.ne.18.030195.000401 Tamura, 1994, Severe radicular pathology in rats with longstanding diabetes, J Neurol Sci, 127, 29, 10.1016/0022-510X(94)90131-7 Taniuchi, 1986, Induction of nerve growth factor receptor in Schwann cells after axotomy, Proc Natl Acad Sci U S A, 83, 4094, 10.1073/pnas.83.11.4094 Tesfaye, 1993, Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography, Diabetologia, 36, 1266, 10.1007/BF00400804 Thomas, 1965, Schwann-cell abnormalities in diabetic neuropathy, Lancet, 62, 1355, 10.1016/S0140-6736(65)92154-9 Thomas, 1966, The pathology of diabetic neuropathy, Q J Med, 140, 489 Thomas, 1980, Changes with age in the peripheral nerves of the rat. An ultrastructural study, Acta Neuropathol, 52, 1, 10.1007/BF00687222 Thomas, 1993, Microscopic anatomy of the peripheral nervous system, 28 Thomas, 1996, Paranodal structure in diabetic sensory polyneuropathy, Acta Neuropathol, 92, 614, 10.1007/s004010050569 Thrainsdottir, 2003, Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man, Diabetes, 52, 2615, 10.2337/diabetes.52.10.2615 Timperley, 1976, Clinical and histological studies in diabetic neuropathy. A reassessment of vascular factors in relation to intravascular coagulation, Diabetologia, 12, 237, 10.1007/BF00422090 Tomlinson, 1992, Aldose reductase inhibitors and diabetic complications, Pharmac Ther, 54, 151, 10.1016/0163-7258(92)90031-T Toth, 2006, Remote neurotrophic support of epidermal nerve fibres in experimental diabetes, Diabetologia, 49, 1081, 10.1007/s00125-006-0169-8 Trapp, 1982, Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin, J Cell Biol, 92, 877, 10.1083/jcb.92.3.877 Trapp, 1981, Immunocytochemical localization of P0 protein in the Golgi complex membranes and myelin of developing rat Schwann cells, J Cell Biol, 90, 1, 10.1083/jcb.90.1.1 Trapp, 1984, Immunocytochemical studies of quaking mice support a role for the myelin-associated glycoprotein in forming and maintaining the periaxonal space and periaxonal collar of myelinating Schwann cells, J Cell Biol, 99, 594, 10.1083/jcb.99.2.594 Uehara, 1997, Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats, J Diabetes Complications, 11, 194, 10.1016/S1056-8727(96)00023-2 Vareniuk, 2007, Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice, Exp Neurol, 205, 425, 10.1016/j.expneurol.2007.03.019 Veves, 1991, The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy, Diabet Med, 8, 917, 10.1111/j.1464-5491.1991.tb01530.x Vincent, 2004, Oxidative stress in the pathogenesis of diabetic neuropathy, Endocr Rev, 25, 612, 10.1210/er.2003-0019 Vlassara, 1983, Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats, Diabetes, 32, 670, 10.2337/diab.32.7.670 Vlassara, 1985, Recognition and uptake of human diabetic peripheral nerve myelin by macrophages, Diabetes, 34, 553, 10.2337/diab.34.6.553 Wada, 1999, Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabtes, Diabetes Metab Res Rev, 15, 332, 10.1002/(SICI)1520-7560(199909/10)15:5<332::AID-DMRR55>3.0.CO;2-L Waldbillig, 1987, Insulin receptors in the peripheral nervous system: a structural and functional analysis, Brain Res, 409, 215, 10.1016/0006-8993(87)90704-9 Walker, 1999, Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat, J Anat, 195, 419, 10.1046/j.1469-7580.1999.19530419.x Walker, 2001, Nerve pathology in the type 1 diabetic dog: effects of treatment with sulindac, J Peripher Nerv Syst, 6, 219, 10.1046/j.1529-8027.2001.01023.x Waxman, 1980, Determinants of conduction velocity in myelinated nerve fibers, Muscle Nerve, 3, 141, 10.1002/mus.880030207 Weiner, 1999, Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid, Proc Natl Acad Sci U S A, 96, 5233, 10.1073/pnas.96.9.5233 Williams, 1980, Electron microscopical studies of vessels in diabetic peripheral neuropathy, J Clin Pathol, 33, 462, 10.1136/jcp.33.5.462 Williams, 1982, Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus, Proc Natl Acad Sci U S A, 79, 6546, 10.1073/pnas.79.21.6546 Wong, 1990, Effects of ciliary neuronotrophic factor (CNTF) on ventral spinal cord neurons in culture, Soc Neurosci Abstr, 16, 384 Wood, 1976, Peripheral nerve glycoproteins and myelin fine structure during development of rat sciatic nerve, J Neurocytol, 5, 605, 10.1007/BF01175573 Yagihashi, 1979, Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy, Tohoku J Exp Med, 129, 357, 10.1620/tjem.129.357 Yagihashi, 1986, Diabetic autonomic neuropathy in BB rat. Ultrastructural and morphometric changes in parasympathetic nerves, Diabetes, 35, 733, 10.2337/diab.35.7.733 Yagihashi, 1979, Morphometrical analysis of the peripheral nerve lesions in experimental diabetes rats, Tohoku J Exp Med, 129, 139, 10.1620/tjem.129.139 Yagihashi, 1982, Peripheral neuropathy in selectively inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies, Tohoku J Exp Med, 138, 39, 10.1620/tjem.138.39 Yagihashi, 1990, Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozotocin-induced diabetic rats, Diabetes, 39, 690, 10.2337/diab.39.6.690 Yagihashi, 1992, Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats, Diabetes, 41, 47, 10.2337/diab.41.1.47 Yagihashi, 1993, Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes, Lab Invest, 68, 296 Yagihashi, 2001, Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor, Brain, 124, 2448, 10.1093/brain/124.12.2448 Yang, 1996, Gangliosides are neuronal ligands for myelin-associated glycoproteins, Proc Natl Acad Sci U S A, 93, 814, 10.1073/pnas.93.2.814 Yasuda, 1987, Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy, Neurology, 37, 20, 10.1212/WNL.37.1.20 Yasuda, 1989, Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozotocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235, Diabetes, 38, 832, 10.2337/diab.38.7.832 Zhang, 2007, C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats, Diabetes Metab Res Rev, 23, 63, 10.1002/dmrr.672 Zochodne, 1999, Diabetic neuropathies: features and mechanisms, Brain Pathol, 9, 369, 10.1111/j.1750-3639.1999.tb00233.x Zochodne, 2004, Accelerated diabetic neuropathy in axons without neurofilaments, Brain, 127, 2193, 10.1093/brain/awh251